May 17, 2026
Headlines

India Healthcare

Aurobindo Pharma Secures Regulatory Approval for Bevacizumab Biosimilar in India

Aurobindo Pharma Secures Regulatory Approval for Bevacizumab Biosimilar in India

Business News Desk03 mins mins

Regulatory Milestone for Aurobindo Pharma Aurobindo Pharma’s subsidiary has received formal marketing authorization from the Central Drugs Standard Control Organization (CDSCO) to distribute Bevqolva, a bevacizumab biosimilar, within the Indian market. The approval, granted under Form CT 23, permits the company to market the drug specifically for the treatment of metastatic carcinoma of the colon…

Read More
Roche Launches 7-Minute Immunotherapy Injection for Lung Cancer in India

Roche Launches 7-Minute Immunotherapy Injection for Lung Cancer in India

Business News Desk03 mins mins

Revolutionizing Cancer Care Delivery Roche Pharma India has officially launched its subcutaneous form of the blockbuster immunotherapy drug Tecentriq (atezolizumab) in India, offering a rapid, seven-minute injection for lung cancer patients. This medical milestone, introduced this month, seeks to replace the traditional intravenous (IV) infusion method, which typically requires 30 to 60 minutes or longer…

Read More